Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Wed, 10 Jun 2026 06:53:38 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngFamilies of SMA and Nationwide Children’s Announce Multi-Million Dollar Award from NINDS to Advance CNS Gene Therapy for Spinal Muscular Atrophyhttp://news.cision.com/families-of-sma/r/families-of-sma-and-nationwide-children-s-announce-multi-million-dollar-award-from-ninds-to-advance-,c9384964cision1271394Wed, 13 Mar 2013 17:00:00 GMTPfizer Licenses Families of Spinal Muscular Atrophy Quinazoline Drug Program from Repligenhttp://news.cision.com/families-of-sma/r/pfizer-licenses-families-of-spinal-muscular-atrophy-quinazoline-drug-program-from-repligen,c9353557cision1209946Thu, 03 Jan 2013 14:15:39 GMTFamilies of Spinal Muscular Atrophy Committed $2.5 Million to Funding SMA Research in 2012http://news.cision.com/families-of-sma/r/families-of-spinal-muscular-atrophy-committed--2-5-million-to-funding-sma-research-in-2012,c9353171cision1208870Mon, 31 Dec 2012 15:00:00 GMTFamilies of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapieshttp://news.cision.com/families-of-sma/r/families-of-spinal-muscular-atrophy-awards--710-000-for-basic-research-to-identify-new-and-more-effe,c9352963cision1208625Fri, 28 Dec 2012 15:00:00 GMTRepligen Initiates Phase 1b Trial of RG3039 for Spinal Muscular Atrophy Licensed from Families of SMAhttp://news.cision.com/families-of-sma/r/repligen-initiates-phase-1b-trial-of-rg3039-for-spinal-muscular-atrophy-licensed-from-families-of-sm,c9310419cision1125342Wed, 26 Sep 2012 20:08:42 GMTFamilies of SMA Announces $1.4 Million Planned for Next Round of Spinal Muscular Atrophy Research Funding.http://news.cision.com/families-of-sma/r/families-of-sma-announces--1-4-million-planned-for-next-round-of-spinal-muscular-atrophy-research-fu,c9270541cision504889Thu, 07 Jun 2012 19:00:00 GMTFamilies of SMA Announces $700,000 Funding for Novel Drug Program at Newly Created California Institute for Biomedical Research.http://news.cision.com/families-of-sma/r/families-of-sma-announces--700-000-funding-for-novel-drug-program-at-newly-created-california-instit,c9258810cision492574Thu, 10 May 2012 19:30:00 GMTFamilies of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophyhttp://news.cision.com/families-of-sma/r/families-of-sma-awards-new-funding-to-advance-a-cns-delivered-gene-therapy-for-spinal-muscular-atrop,c9254738cision488353Wed, 02 May 2012 20:00:00 GMTRepligen Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA).http://news.cision.com/families-of-sma/r/repligen-reports-positive-results-from-phase-1-clinical-trial-for-spinal-muscular-atrophy--sma-,c9251546cision484670Wed, 25 Apr 2012 14:23:22 GMTUpdate on the Spinal Muscular Atrophy Drug Development Pipeline from Families of SMAhttp://news.cision.com/families-of-sma/r/update-on-the-spinal-muscular-atrophy-drug-development-pipeline-from-families-of-sma,c9208761cision440867Thu, 19 Jan 2012 15:00:00 GMTFamilies of Spinal Muscular Atrophy Releases SMA Care Series Booklet on Nutrition Basics for SMAhttp://news.cision.com/families-of-sma/r/families-of-spinal-muscular-atrophy-releases-sma-care-series-booklet-on-nutrition-basics-for-sma,c9205909cision437732Tue, 10 Jan 2012 19:51:44 GMT